Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy (VOCAL)

NCT03837327 is registered in ClinicalTrials.gov with Venn Biosciences Corporation as lead sponsor.

NCT NCT03837327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03837327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy (VOCAL)
Lead sponsor
Venn Biosciences Corporation
Phase
Observational
Overall status
Completed
Start date
April 16, 2019
Completion date
January 22, 2024
Enrollment
1,025 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

adnexal mass, ovarian cancer, pelvic mass